がんバイオセラピーの世界市場 2020年

• 英文タイトル：Global Cancer Biotherapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201113791 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、がんバイオセラピーの世界市場を調査対象にし、がんバイオセラピーの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（モノクローナル抗体、ワクチン、エリスロポエチン、コロニー刺激因子、インターロイキン、インターフェロン）、用途別分析（病院、診断研究所、研究及び学術研究所、製薬及びバイオテクノロジー企業、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Amgen、GlaxoSmithKline、Bristol-Myers Squibb、Celgene、Eli Lilly ・企業別売上、市場シェア ・がんバイオセラピーの地域別市場分析 ・がんバイオセラピーの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・がんバイオセラピーのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・がんバイオセラピーのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・がんバイオセラピーの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・がんバイオセラピーの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・がんバイオセラピーの種類別市場規模2015-2020：モノクローナル抗体、ワクチン、エリスロポエチン、コロニー刺激因子、インターロイキン、インターフェロン ・がんバイオセラピーの用途別市場規模2015-2020：病院、診断研究所、研究及び学術研究所、製薬及びバイオテクノロジー企業、その他 ・がんバイオセラピーの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Cancer Biotherapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Cancer Biotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Cancer Biotherapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Cancer Biotherapy market has been segmented into:
Monoclonal Antibodies
Vaccines
Erythropoietin
Colony Stimulating Factors
Interleukins and Interferons

By Application, Cancer Biotherapy has been segmented into:
Hospitals
Diagnostic Laboratories
Research and Academic Laboratories
Pharmaceutical and Biotechnology Companies
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Biotherapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Biotherapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Biotherapy market.

The report offers in-depth assessment of the growth and other aspects of the Cancer Biotherapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Cancer Biotherapy Market Share Analysis
Cancer Biotherapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Biotherapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Biotherapy sales, revenue and market share for each player covered in this report.

The major players covered in Cancer Biotherapy are:
Amgen
GlaxoSmithKline
Bristol-Myers Squibb
Celgene
Eli Lilly

レポート目次

---

1 Cancer Biotherapy Market Overview
1.1 Product Overview and Scope of Cancer Biotherapy
1.2 Classification of Cancer Biotherapy by Type
1.2.1 Global Cancer Biotherapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cancer Biotherapy Revenue Market Share by Type in 2019
1.2.3 Monoclonal Antibodies
1.2.4 Vaccines
1.2.5 Erythropoietin
1.2.6 Colony Stimulating Factors
1.2.7 Interleukins and Interferons
1.3 Global Cancer Biotherapy Market by Application
1.3.1 Overview: Global Cancer Biotherapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research and Academic Laboratories
1.3.5 Pharmaceutical and Biotechnology Companies
1.3.6 Others
1.4 Global Cancer Biotherapy Market by Regions
1.4.1 Global Cancer Biotherapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cancer Biotherapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cancer Biotherapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cancer Biotherapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Biotherapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cancer Biotherapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Biotherapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Cancer Biotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline Cancer Biotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb SWOT Analysis
2.3.4 Bristol-Myers Squibb Product and Services
2.3.5 Bristol-Myers Squibb Cancer Biotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Celgene
2.4.1 Celgene Details
2.4.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Celgene SWOT Analysis
2.4.4 Celgene Product and Services
2.4.5 Celgene Cancer Biotherapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Cancer Biotherapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancer Biotherapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Biotherapy Players Market Share
3.2.2 Top 10 Cancer Biotherapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cancer Biotherapy Revenue and Market Share by Regions
4.2 North America Cancer Biotherapy Revenue and Growth Rate (2015-2020)
4.3 Europe Cancer Biotherapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Biotherapy Revenue and Growth Rate (2015-2020)
4.5 South America Cancer Biotherapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cancer Biotherapy Revenue and Growth Rate (2015-2020)
5 North America Cancer Biotherapy Revenue by Countries
5.1 North America Cancer Biotherapy Revenue by Countries (2015-2020)
5.2 USA Cancer Biotherapy Revenue and Growth Rate (2015-2020)
5.3 Canada Cancer Biotherapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Cancer Biotherapy Revenue and Growth Rate (2015-2020)
6 Europe Cancer Biotherapy Revenue by Countries
6.1 Europe Cancer Biotherapy Revenue by Countries (2015-2020)
6.2 Germany Cancer Biotherapy Revenue and Growth Rate (2015-2020)
6.3 UK Cancer Biotherapy Revenue and Growth Rate (2015-2020)
6.4 France Cancer Biotherapy Revenue and Growth Rate (2015-2020)
6.5 Russia Cancer Biotherapy Revenue and Growth Rate (2015-2020)
6.6 Italy Cancer Biotherapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cancer Biotherapy Revenue by Countries
7.1 Asia-Pacific Cancer Biotherapy Revenue by Countries (2015-2020)
7.2 China Cancer Biotherapy Revenue and Growth Rate (2015-2020)
7.3 Japan Cancer Biotherapy Revenue and Growth Rate (2015-2020)
7.4 Korea Cancer Biotherapy Revenue and Growth Rate (2015-2020)
7.5 India Cancer Biotherapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Biotherapy Revenue and Growth Rate (2015-2020)
8 South America Cancer Biotherapy Revenue by Countries
8.1 South America Cancer Biotherapy Revenue by Countries (2015-2020)
8.2 Brazil Cancer Biotherapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Cancer Biotherapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cancer Biotherapy by Countries
9.1 Middle East & Africa Cancer Biotherapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cancer Biotherapy Revenue and Growth Rate (2015-2020)
9.3 UAE Cancer Biotherapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Cancer Biotherapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Cancer Biotherapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cancer Biotherapy Revenue and Market Share by Type (2015-2020)
10.2 Global Cancer Biotherapy Market Forecast by Type (2019-2024)
10.3 Monoclonal Antibodies Revenue Growth Rate (2015-2025)
10.4 Vaccines Revenue Growth Rate (2015-2025)
10.5 Erythropoietin Revenue Growth Rate (2015-2025)
10.6 Colony Stimulating Factors Revenue Growth Rate (2015-2025)
10.7 Interleukins and Interferons Revenue Growth Rate (2015-2025)
11 Global Cancer Biotherapy Market Segment by Application
11.1 Global Cancer Biotherapy Revenue Market Share by Application (2015-2020)
11.2 Cancer Biotherapy Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Diagnostic Laboratories Revenue Growth (2015-2020)
11.5 Research and Academic Laboratories Revenue Growth (2015-2020)
11.6 Pharmaceutical and Biotechnology Companies Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Cancer Biotherapy Market Size Forecast (2021-2025)
12.1 Global Cancer Biotherapy Market Size Forecast (2021-2025)
12.2 Global Cancer Biotherapy Market Forecast by Regions (2021-2025)
12.3 North America Cancer Biotherapy Revenue Market Forecast (2021-2025)
12.4 Europe Cancer Biotherapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cancer Biotherapy Revenue Market Forecast (2021-2025)
12.6 South America Cancer Biotherapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cancer Biotherapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Cancer Biotherapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Biotherapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Biotherapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cancer Biotherapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Amgen Corporate Information, Location and Competitors
Table 6. Amgen Cancer Biotherapy Major Business
Table 7. Amgen Cancer Biotherapy Total Revenue (USD Million) (2017-2018)
Table 8. Amgen SWOT Analysis
Table 9. Amgen Cancer Biotherapy Product and Solutions
Table 10. Amgen Cancer Biotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. GlaxoSmithKline Corporate Information, Location and Competitors
Table 12. GlaxoSmithKline Cancer Biotherapy Major Business
Table 13. GlaxoSmithKline Cancer Biotherapy Total Revenue (USD Million) (2018-2019)
Table 14. GlaxoSmithKline SWOT Analysis
Table 15. GlaxoSmithKline Cancer Biotherapy Product and Solutions
Table 16. GlaxoSmithKline Cancer Biotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 18. Bristol-Myers Squibb Cancer Biotherapy Major Business
Table 19. Bristol-Myers Squibb Cancer Biotherapy Total Revenue (USD Million) (2017-2018)
Table 20. Bristol-Myers Squibb SWOT Analysis
Table 21. Bristol-Myers Squibb Cancer Biotherapy Product and Solutions
Table 22. Bristol-Myers Squibb Cancer Biotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Celgene Corporate Information, Location and Competitors
Table 24. Celgene Cancer Biotherapy Major Business
Table 25. Celgene Cancer Biotherapy Total Revenue (USD Million) (2017-2018)
Table 26. Celgene SWOT Analysis
Table 27. Celgene Cancer Biotherapy Product and Solutions
Table 28. Celgene Cancer Biotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Eli Lilly Corporate Information, Location and Competitors
Table 30. Eli Lilly Cancer Biotherapy Major Business
Table 31. Eli Lilly Cancer Biotherapy Total Revenue (USD Million) (2017-2018)
Table 32. Eli Lilly SWOT Analysis
Table 33. Eli Lilly Cancer Biotherapy Product and Solutions
Table 34. Eli Lilly Cancer Biotherapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Cancer Biotherapy Revenue (Million USD) by Players (2015-2020)
Table 36. Global Cancer Biotherapy Revenue Share by Players (2015-2020)
Table 37. Global Cancer Biotherapy Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Cancer Biotherapy Revenue Market Share by Regions (2015-2020)
Table 39. North America Cancer Biotherapy Revenue by Countries (2015-2020)
Table 40. North America Cancer Biotherapy Revenue Market Share by Countries (2015-2020)
Table 41. Europe Cancer Biotherapy Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Cancer Biotherapy Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Cancer Biotherapy Revenue by Countries (2015-2020)
Table 44. South America Cancer Biotherapy Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Cancer Biotherapy Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Cancer Biotherapy Revenue Market Share by Countries (2015-2020)
Table 47. Global Cancer Biotherapy Revenue (Million USD) by Type (2015-2020)
Table 48. Global Cancer Biotherapy Revenue Share by Type (2015-2020)
Table 49. Global Cancer Biotherapy Revenue Forecast by Type (2021-2025)
Table 50. Global Cancer Biotherapy Revenue by Application (2015-2020)
Table 51. Global Cancer Biotherapy Revenue Share by Application (2015-2020)
Table 52. Global Cancer Biotherapy Revenue Forecast by Application (2021-2025)
Table 53. Global Cancer Biotherapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cancer Biotherapy Picture
Figure 2. Global Cancer Biotherapy Revenue Market Share by Type in 2019
Figure 3. Monoclonal Antibodies Picture
Figure 4. Vaccines Picture
Figure 5. Erythropoietin Picture
Figure 6. Colony Stimulating Factors Picture
Figure 7. Interleukins and Interferons Picture
Figure 8. Cancer Biotherapy Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Diagnostic Laboratories Picture
Figure 11. Research and Academic Laboratories Picture
Figure 12. Pharmaceutical and Biotechnology Companies Picture
Figure 13. Others Picture
Figure 14. Global Cancer Biotherapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Cancer Biotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Cancer Biotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Cancer Biotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Cancer Biotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Cancer Biotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Cancer Biotherapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Cancer Biotherapy Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Cancer Biotherapy Revenue Market Share in 2019
Figure 23. Global Top 10 Players Cancer Biotherapy Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Cancer Biotherapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Cancer Biotherapy Revenue Market Share by Regions (2015-2020)
Figure 27. Global Cancer Biotherapy Revenue Market Share by Regions in 2018
Figure 28. North America Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 29. Europe Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 31. South America Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 33. North America Cancer Biotherapy Revenue Market Share by Countries (2015-2020)
Figure 34. North America Cancer Biotherapy Revenue Market Share by Countries in 2019
Figure 35. USA Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 36. Canada Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 38. Europe Cancer Biotherapy Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Cancer Biotherapy Revenue Market Share by Countries in 2019
Figure 40. Germany Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 41. UK Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 42. France Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 43. Russia Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 44. Italy Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Cancer Biotherapy Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Cancer Biotherapy Revenue Market Share by Countries in 2019
Figure 47. China Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 48. Japan Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 49. Korea Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 50. India Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 52. South America Cancer Biotherapy Revenue Market Share by Countries (2015-2020)
Figure 53. South America Cancer Biotherapy Revenue Market Share by Countries in 2019
Figure 54. Brazil Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Cancer Biotherapy Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Cancer Biotherapy Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 59. UAE Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Cancer Biotherapy Revenue and Growth Rate (2015-2020)
Figure 62. Global Cancer Biotherapy Revenue Share by Type (2015-2020)
Figure 63. Global Cancer Biotherapy Revenue Share by Type in 2019
Figure 64. Global Cancer Biotherapy Market Share Forecast by Type (2021-2025)
Figure 65. Global Monoclonal Antibodies Revenue Growth Rate (2015-2020)
Figure 66. Global Vaccines Revenue Growth Rate (2015-2020)
Figure 67. Global Erythropoietin Revenue Growth Rate (2015-2020)
Figure 68. Global Colony Stimulating Factors Revenue Growth Rate (2015-2020)
Figure 69. Global Interleukins and Interferons Revenue Growth Rate (2015-2020)
Figure 70. Global Cancer Biotherapy Revenue Share by Application (2015-2020)
Figure 71. Global Cancer Biotherapy Revenue Share by Application in 2019
Figure 72. Global Cancer Biotherapy Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 74. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 75. Global Research and Academic Laboratories Revenue Growth Rate (2015-2020)
Figure 76. Global Pharmaceutical and Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 77. Global Others Revenue Growth Rate (2015-2020)
Figure 78. Global Cancer Biotherapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Cancer Biotherapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Cancer Biotherapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Cancer Biotherapy Revenue Market Forecast (2021-2025)
Figure 82. Europe Cancer Biotherapy Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Cancer Biotherapy Revenue Market Forecast (2021-2025)
Figure 84. South America Cancer Biotherapy Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Cancer Biotherapy Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel

---